108 related articles for article (PubMed ID: 24838931)
1. Molecular signatures and transcriptional regulatory networks of human immature decidual NK and mature peripheral NK cells.
Wang F; Zhou Y; Fu B; Wu Y; Zhang R; Sun R; Tian Z; Wei H
Eur J Immunol; 2014 Sep; 44(9):2771-84. PubMed ID: 24838931
[TBL] [Abstract][Full Text] [Related]
2. CD56brightCD16+ NK cells: a functional intermediate stage of NK cell differentiation.
Béziat V; Duffy D; Quoc SN; Le Garff-Tavernier M; Decocq J; Combadière B; Debré P; Vieillard V
J Immunol; 2011 Jun; 186(12):6753-61. PubMed ID: 21555534
[TBL] [Abstract][Full Text] [Related]
3. The small subset of CD56brightCD16- natural killer cells is selectively responsible for both cell proliferation and interferon-gamma production upon interaction with dendritic cells.
Vitale M; Della Chiesa M; Carlomagno S; Romagnani C; Thiel A; Moretta L; Moretta A
Eur J Immunol; 2004 Jun; 34(6):1715-22. PubMed ID: 15162442
[TBL] [Abstract][Full Text] [Related]
4. CD16 cross-linking induces increased expression of CD56 and production of IL-12 in peripheral NK cells.
Márquez ME; Millet C; Stekman H; Conesa A; Deglesne PA; Toro F; Sanctis JD; Blanca I
Cell Immunol; 2010; 264(1):86-92. PubMed ID: 20553754
[TBL] [Abstract][Full Text] [Related]
5. Cord blood CD16+56- cells with low lytic activity are possible precursors of mature natural killer cells.
Gaddy J; Broxmeyer HE
Cell Immunol; 1997 Sep; 180(2):132-42. PubMed ID: 9341743
[TBL] [Abstract][Full Text] [Related]
6. Immune status of Fanconi anemia patients: decrease in T CD8 and CD56dim CD16+ NK lymphocytes.
Justo GA; Bitencourt MA; Pasquini R; Castelo-Branco MT; Almeida-Oliveira A; Diamond HR; Rumjanek VM
Ann Hematol; 2014 May; 93(5):761-7. PubMed ID: 24240977
[TBL] [Abstract][Full Text] [Related]
7. The CD6 scavenger receptor is differentially expressed on a CD56 natural killer cell subpopulation and contributes to natural killer-derived cytokine and chemokine secretion.
Braun M; Müller B; ter Meer D; Raffegerst S; Simm B; Wilde S; Spranger S; Ellwart J; Mosetter B; Umansky L; Lerchl T; Schendel DJ; Falk CS
J Innate Immun; 2011; 3(4):420-34. PubMed ID: 21178331
[TBL] [Abstract][Full Text] [Related]
8. An increase in the absolute count of CD56dimCD16+CD69+ NK cells in the peripheral blood is associated with a poorer IVF treatment and pregnancy outcome.
Thum MY; Bhaskaran S; Abdalla HI; Ford B; Sumar N; Shehata H; Bansal AS
Hum Reprod; 2004 Oct; 19(10):2395-400. PubMed ID: 15319390
[TBL] [Abstract][Full Text] [Related]
9. Induction of CD16+ CD56bright NK cells with antitumour cytotoxicity not only from CD16- CD56bright NK Cells but also from CD16- CD56dim NK cells.
Takahashi E; Kuranaga N; Satoh K; Habu Y; Shinomiya N; Asano T; Seki S; Hayakawa M
Scand J Immunol; 2007 Feb; 65(2):126-38. PubMed ID: 17257217
[TBL] [Abstract][Full Text] [Related]
10. CD160: a unique activating NK cell receptor.
Le Bouteiller P; Tabiasco J; Polgar B; Kozma N; Giustiniani J; Siewiera J; Berrebi A; Aguerre-Girr M; Bensussan A; Jabrane-Ferrat N
Immunol Lett; 2011 Aug; 138(2):93-6. PubMed ID: 21324341
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic study of natural killer cell subsets in ankylosing spondylitis patients.
Mousavi T; Poormoghim H; Moradi M; Tajik N; Shahsavar F; Soofi M
Iran J Allergy Asthma Immunol; 2009 Dec; 8(4):193-8. PubMed ID: 20404389
[TBL] [Abstract][Full Text] [Related]
12. Differential transcription of Eomes and T-bet during maturation of mouse uterine natural killer cells.
Tayade C; Fang Y; Black GP; V A P; Erlebacher A; Croy BA
J Leukoc Biol; 2005 Dec; 78(6):1347-55. PubMed ID: 16204645
[TBL] [Abstract][Full Text] [Related]
13. Phenotype and function of natural killer cells in systemic lupus erythematosus: excess interferon-γ production in patients with active disease.
Hervier B; Beziat V; Haroche J; Mathian A; Lebon P; Ghillani-Dalbin P; Musset L; Debré P; Amoura Z; Vieillard V
Arthritis Rheum; 2011 Jun; 63(6):1698-706. PubMed ID: 21370226
[TBL] [Abstract][Full Text] [Related]
14. Natural killer cells infiltrating human nonsmall-cell lung cancer are enriched in CD56 bright CD16(-) cells and display an impaired capability to kill tumor cells.
Carrega P; Morandi B; Costa R; Frumento G; Forte G; Altavilla G; Ratto GB; Mingari MC; Moretta L; Ferlazzo G
Cancer; 2008 Feb; 112(4):863-75. PubMed ID: 18203207
[TBL] [Abstract][Full Text] [Related]
15. Skin infiltration of CD56(bright) CD16(-) natural killer cells in a case of X-SCID with Omenn syndrome-like manifestations.
Shibata F; Toma T; Wada T; Inoue M; Tone Y; Ohta K; Kasahara Y; Sano F; Kimura M; Ikeno M; Koizumi S; Yachie A
Eur J Haematol; 2007 Jul; 79(1):81-5. PubMed ID: 17598841
[TBL] [Abstract][Full Text] [Related]
16. A novel epitope of N-CAM defines precursors of human adherent NK cells.
Li S; Xu J; Makarenkova VP; Tjandrawan T; Vakkila J; Reichert T; Gooding W; Lagenaur CF; Achim CL; Chambers WH; Herberman RB; Whiteside TL; Vujanovic NL
J Leukoc Biol; 2004 Dec; 76(6):1187-99. PubMed ID: 15356097
[TBL] [Abstract][Full Text] [Related]
17. Mature cytotoxic CD56(bright)/CD16(+) natural killer cells can infiltrate lymph nodes adjacent to metastatic melanoma.
Messaoudene M; Fregni G; Fourmentraux-Neves E; Chanal J; Maubec E; Mazouz-Dorval S; Couturaud B; Girod A; Sastre-Garau X; Albert S; Guédon C; Deschamps L; Mitilian D; Cremer I; Jacquelot N; Rusakiewicz S; Zitvogel L; Avril MF; Caignard A
Cancer Res; 2014 Jan; 74(1):81-92. PubMed ID: 24225017
[TBL] [Abstract][Full Text] [Related]
18. Immunosenescence of human natural killer cells.
Gayoso I; Sanchez-Correa B; Campos C; Alonso C; Pera A; Casado JG; Morgado S; Tarazona R; Solana R
J Innate Immun; 2011; 3(4):337-43. PubMed ID: 21576928
[TBL] [Abstract][Full Text] [Related]
19. Immunophenotype of peripheral blood natural killer cells and IL-10 serum levels in relation to Helicobacter pylori status.
Rudnicka K; Matusiak A; Miszczyk E; Rudnicka W; Tenderenda M; Chmiela M
APMIS; 2013 Sep; 121(9):806-13. PubMed ID: 23758061
[TBL] [Abstract][Full Text] [Related]
20. Viral load reduction improves activation and function of natural killer cells in patients with chronic hepatitis B.
Tjwa ET; van Oord GW; Hegmans JP; Janssen HL; Woltman AM
J Hepatol; 2011 Feb; 54(2):209-18. PubMed ID: 21095036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
